Free Trial

Panbela Therapeutics (PBLA) SEC Filings & 10K Form

$0.34
0.00 (0.00%)
(As of 07/26/2024 ET)

Recent Panbela Therapeutics SEC Filings

DateFilerForm TypeView
07/03/2024
3:46 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:00 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:21 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:22 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:24 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:27 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
7:29 PM
Panbela Therapeutics (Filer)
Form 424B3
05/15/2024
3:16 PM
Panbela Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
3:35 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
8:09 AM
Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
Form 25-NSE
04/22/2024
7:02 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
3:31 PM
Panbela Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/17/2024
7:36 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
04/04/2024
3:17 PM
Panbela Therapeutics (Filer)
Form DEF 14A
04/02/2024
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
03/29/2024
4:08 PM
Panbela Therapeutics (Filer)
Form POS AM
03/29/2024
4:24 PM
Panbela Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2024
3:15 PM
Panbela Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:12 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:01 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
7:05 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:10 PM
Lind Global Fund II LP (Filed by)
Panbela Therapeutics (Subject)
Form SC 13G/A
02/13/2024
4:24 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
6:15 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
4:28 PM
Panbela Therapeutics (Filer)
Form 424B4
01/29/2024
5:21 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2024
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
01/25/2024
11:22 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/25/2024
7:54 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/22/2024
5:08 AM
Panbela Therapeutics (Filer)
Form S-1/A
01/19/2024
4:20 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:34 PM
Panbela Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/05/2024
11:48 AM
Panbela Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/21/2023
8:25 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2023
8:25 AM
Panbela Therapeutics (Filer)
Form DEFA14A
12/20/2023
11:15 PM
Panbela Therapeutics (Filer)
Form EFFECT
12/21/2023
5:00 AM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
3:30 PM
Panbela Therapeutics (Filer)
Form DEF 14A
11/13/2023
6:27 PM
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
6:29 PM
GOLDMAN SACHS & CO. LLC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
GOLDMAN SACHS GROUP INC (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Get out of cash before the Fed's next meeting (Ad)

"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."

Click here now to watch this exclusive interview
11/03/2023
4:24 PM
Panbela Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
4:25 PM
Panbela Therapeutics (Filer)
Form DEFA14A
09/14/2023
3:06 PM
Jacob Jeffrey E. (Reporting)
Panbela Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PBLA) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners